Press Release PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002 PharmAla Biotech · Jul 21
Press Release Bombardier Defense Announces 10-Year Services Support Agreement with Swedish Armed Forces for Fleet Modernization Initiative Bombardier Inc. · Jul 21
Press Release Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock Dyne Therapeutics, Inc. · Jul 21
Press Release Turntide to Expand High-Voltage Rail Battery Production at Its Sunderland Site Turntide Technologies · Jul 21
Press Release FREELANDER Middle East Launch Countdown — British Premium SUV Setting a New Global Benchmark for Intelligent Parking with SIVP Chery Group · Jul 21
Press Release Berkshire Hathaway HomeServices Bayside Realty Recognizes Diana Burgon’s Award-Winning Real Estate Leadership Berkshire Hathaway HomeServices · Jul 21
Press Release Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance Picard Medical, Inc. · Jul 21
Press Release Vivideo.ai Expands AI Video Platform With Unified Multi-Model Workflow and Expanded Avatar and Voice Tools Vivideo.ai · Jul 21
Press Release ZTB Capital Lowers Minimum Investment for ZTB Quantum Fund to $2,000 ZTB Capital · Jul 21
Press Release AirJoule Technologies and Kubota Corporation Announce Deployments of Breakthrough Decentralized Water Infrastructure and Exclusive Sales Partnership to Unlock Water-Constrained U.S. Residential Development AirJoule Technologies Corporation · Jul 21
Press Release MAGFAST Reopens “Christmas in July” by Popular Demand — and Teases a Live Reveal With Three Surprises MAGFAST · Jul 21
Press Release YRI Fellowship Launches Elite “Top 1% Program” to Engineer Comprehensive University Admission Portfolios for Ambitious Youth YRI Fellowship · Jul 21
Press Release Junshi Biosciences Announces Acceptance of the Supplemental Application for Toripalimab plus Chemotherapy as Perioperative Treatment for Resectable Stage Ⅱ-Ⅲ NSCLC Junshi Biosciences · Jul 21